(1) Prostate cancer has reached epidemic pro-
portions, particularly among African-American men, 
and strikes and kills men in numbers comparable to 
the number of women who lose their lives from 
breast cancer. 
(2) Life-saving breakthroughs in screening, di-
agnosis, and treatment of breast cancer resulted 
from the development of advanced imaging tech-
nologies led by the Federal Government. 
(3) Men should have accurate and affordable 
prostate cancer screening exams and minimally- 
invasive treatment tools, similar to what women have 
for breast cancer. 
(4) While it is important for men to take ad-
vantage of current prostate cancer screening tech-
niques, a recent NCI-funded study demonstrated 
that the most common available methods of detect-
ing prostate cancer (PSA blood test and physical 
exams) are not foolproof, causing numerous false 
alarms and false reassurances. 
(5) The absence of advanced imaging tech-
nologies for prostate cancer causes the lack of accu-
rate information critical for clinical decisions, result-
ing in missed cancers and lost lives, as well as un-
VerDate Aug 31 2005 
22:04 Sep 20, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3563.IH
H3563
mstockstill on PROD1PC66 with BILLS
necessary and costly medical procedures, with re-
lated complications. 
(6) With prostate imaging tools, men and their 
families would face less physical, psychological, fi-
nancial and emotional trauma and billions of dollars 
could be saved in private and public health care sys-
tems. 
SEC. 3. RESEARCH AND DEVELOPMENT OF PROSTATE CAN-
CER IMAGING TECHNOLOGIES. 
(a) EXPANSION OF RESEARCH.—The Secretary of 
Health and Human Services (referred to in this Act as 
the ‘‘Secretary’’), acting through the Director of the Na-
tional Institutes of Health and the Administrator of the 
Health Resources and Services Administration, and in 
consultation with the Secretary of Defense, shall carry out 
a program to expand and intensify research to develop in-
novative advanced imaging technologies for prostate can-
cer detection, diagnosis, and treatment comparable to 
state-of-the-art mammography technologies. 
(b) EARLY STAGE RESEARCH.—In implementing the 
program under subsection (a), the Secretary, acting 
through the Administrator of the Health Resources and 
Services Administration, shall carry out a grant program 
to encourage the early stages of research in prostate imag-
ing to develop and implement new ideas, proof of concepts, 
VerDate Aug 31 2005 
22:04 Sep 20, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3563.IH
H3563
mstockstill on PROD1PC66 with BILLS
and pilot studies for high-risk technologic innovation in 
prostate cancer imaging that would have a high potential 
impact for improving patient care, including individualized 
care, quality of life, and cost-effectiveness. 
(c) LARGE SCALE LATER STAGE RESEARCH.—In im-
plementing the program under subsection (a), the Sec-
retary, acting through the Director of the National Insti-
tutes of Health, shall utilize the National Institute of Bio-
medical Imaging and Bioengineering and the National 
Cancer Institute for advanced stages of research in pros-
tate imaging, including technology development and clin-
ical trials for projects determined by the Secretary to have 
demonstrated promising preliminary results and proof of 
concept. 
(d) INTERDISCIPLINARY PRIVATE-PUBLIC PARTNER-
SHIPS.—In developing the program under subsection (a), 
the Secretary, through the Administrator of the Health 
Resources and Services Administration, shall establish 
interdisciplinary private-public partnerships to develop 
and implement research strategies for expedited innova-
tion in imaging and image-guided treatment and to con-
duct such research. 
(e) RACIAL DISPARITIES.—In developing the pro-
gram under subsection (a), the Secretary shall recognize 
and address— 
VerDate Aug 31 2005 
22:04 Sep 20, 2007
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3563.IH
H3563
mstockstill on PROD1PC66 with BILLS
(1) the racial disparities in the incidences of 
prostate cancer and mortality rates with respect to 
such disease; and 
(2) any barriers in access to care and participa-
tion in clinical trials that are specific to racial mi-
norities. 
(f) AUTHORIZATION OF APPROPRIATIONS.— 
(1) IN GENERAL.—Subject to paragraph (2), 
there is authorized to be appropriated to carry out 
this section, $100,000,000 for each of the fiscal 
years 2008 through 2012. 
(2) SPECIFIC
ALLOCATIONS.—Of the amount 
authorized to be appropriated under paragraph (1) 
for each of the fiscal years described in such para-
graph— 
(A) no less than 10 percent may be appro-
priated to carry out the grant program under 
subsection (b); and 
(B) no more than 1 percent may be appro-
priated to carry out subsection (d). 
SEC. 4. PUBLIC AWARENESS AND EDUCATION CAMPAIGN. 
(a) NATIONAL CAMPAIGN.—The Secretary shall carry 
out a national campaign to increase the awareness and 
knowledge of Americans with respect to the need for pros-
VerDate Aug 31 2005 
23:55 Sep 20, 2007
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H3563.IH
H3563
mstockstill on PROD1PC66 with BILLS
tate cancer screening and for improved detection tech-
nologies. 
(b) REQUIREMENTS.—The national campaign con-
ducted under subsection (a) shall include— 
(1) roles for the Health Resources Services Ad-
ministration, the Office on Minority Health of the 
Department of Health and Human Services, the 
Centers for Disease Control and Prevention, and the 
Office of Minority Health of the Centers for Disease 
Control and Prevention; and 
(2) the development and distribution of written 
educational materials, and the development and 
placing of public service announcements, that are in-
tended to encourage men to seek prostate cancer 
screening and to create awareness of the need for 
improved imaging technologies for prostate cancer 
screening and diagnosis, including in vitro blood 
testing and imaging technologies. 
(c) RACIAL DISPARITIES.—In developing the national 
campaign under subsection (a), the Secretary shall recog-
nize and address— 
(1) the racial disparities in the incidences of 
prostate cancer and mortality rates with respect to 
such disease; and 
VerDate Aug 31 2005 
22:04 Sep 20, 2007
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3563.IH
H3563
mstockstill on PROD1PC66 with BILLS
Secretary shall submit to Congress a report that details 
the strategy of the Secretary for implementing the require-
ments of this Act and the status of such efforts. 
(b) FULL COMPLIANCE.—Not later than 1 year after 
the date of the enactment of this Act, and annually there-
after, the Secretary shall submit to Congress a report 
that— 
(1) describes the research and development and 
public awareness and education campaigns funded 
under this Act; 
(2) provides evidence that projects involving 
high-risk, high impact technologic innovation, proof 
of concept, and pilot studies are prioritized; 
(3) provides evidence that the Secretary recog-
nizes and addresses any barriers in access to care 
and participation in clinical trials that are specific to 
racial minorities in the implementation of this Act; 
(4) contains assurances that the all other provi-
sions of this Act are fully implemented; and 
(5) certifies compliance with the provisions of 
this Act, or in the case of a Federal agency that has 
not complied with any of such provisions, an expla-
nation as to such failure to comply. 
Æ 
VerDate Aug 31 2005 
22:04 Sep 20, 2007
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H3563.IH
H3563
mstockstill on PROD1PC66 with BILLS